MK Sharief, DA Ingram, M Swash, EJ Thompson - Neurology, 1999 - AAN Enterprises
Background: Treatment with human IV immunoglobulin (IVIg) modifies the course of Guillain-
Barré syndrome (GBS), but its specific mode of action is unknown. Cellular interactions …